KFGK
PRME icon

Keystone Financial Group (Kentucky)’s Prime Medicine PRME Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$578K Buy
166,010
+36,345
+28% +$138K 0.04% 271
2025
Q4 		$450K Buy
129,665
+58,810
+83% +$262K 0.03% 273
2025
Q3 		$393K Buy
+70,855
New +$288K 0.03% 273

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s PRME Position: Q1 2026 in Review

Keystone Financial Group (Kentucky) increased its Prime Medicine (PRME) stake by 28% in Q1 2026, buying an estimated $138K and bringing the position to 166,010 shares worth $578K. The position accounts for 0.04% of the portfolio, ranked #271.

Keystone Financial Group (Kentucky) first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Keystone Financial Group (Kentucky) held 166,010 shares of Prime Medicine worth $578K as of Q1 2026.
  • Keystone Financial Group (Kentucky) bought 36,345 Prime Medicine shares in Q1 2026, an estimated $138K.
  • Prime Medicine made up 0.04% of Keystone Financial Group (Kentucky)'s portfolio in Q1 2026, its #271 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q1 2026, filed 13 May 2026.